The Emergence of Anti-Counterfeiting Legislation in East Africa: Implications for Generic Supply and Treatment Access Mandeep Dhaliwal Tenu Avafia With.

Slides:



Advertisements
Similar presentations
External Trade 1 5th Global Congress Combating Counterfeiting and Piracy Global and Regional IPR Enforcement Initiatives Luc-Pierre Devigne Head of Intellectual.
Advertisements

4 th Global Congress Combating Counterfeiting & Piracy Dubai, February 3-8, 2008 Challenge 7 : Strengthening Cooperation and Collaboration at the Global.
1 n European Commission 4th Global Congress: Combating Counterfeiting and Piracy Dubai – 3 February 2008 An Urgent Need to Better Respond to the Global.
Fourth Global Congress on Combating Counterfeiting and Piracy WIPO Development Agenda: a New Global Initiative Dubai February 3 to 5, 2008 Pushpendra Rai.
Least Developed Countries: IP Needs Assessment: WIPO, WTO and the LDC needs assessment process under TRIPS WIPO Conference on Building Partnerships for.
1 n European Commission Third Global Congress on Combating Counterfeiting and Piracy Geneva – 30 and 31 January 2007 The European Union: Coordination and.
ISSUES AND CONCERNS IN THE UGANDA COUNTERFEIT GOODS BILL MULUMBA, MOSES.
Working world wide against HIV for the health and human rights of men who have sex with men Working world wide against HIV for the health and human rights.
Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.
The new offensive on enforcement of IPRs Domestic and international actions Domestic and international actions Pressures on developing countries Pressures.
The Monopoly Enforcement Agenda: A Global Overview Peter Maybarduk Essential Action 29 May 2009 Peter Maybarduk Essential Action 29 May 2009.
Community Perspective on IP use to ensure Acces to medicines Nelson Juma Otwoma UNITAID CF, Geneva. 4/5, October 2011.
J.P. Singh Georgetown University Communication, Culture, & Technology Program TRIPS: Negotiating Intellectual Property in the World Trading System J.
WTO Dispute DS362 China vs. United States
World Intellectual Property Organization (WIPO) Dispute Settlement and Effective Enforcement of IP.
RECOMMENDATIONS BY INTELLECTUAL PROPERTY LAWYERS ON LEGAL REFORM MOSES NKOMO LL.B, MIP.
Office of the U.S. Trade Representative Kira M. Alvarez CHIEF NEGOTIATOR AND DEPUTY ASSISTANT U.S.T.R. For intellectual property enforcement.
“Using Competition Law to Promote Access to Health Technologies” Access to Innovation: Making Generic Versions of Newer ARVs Affordable 24 July 2014 Melbourne,
Challenges and Opportunities to Utilize TRIPS Flexibilities in Current Ukrainian Legislation: Potential Impact of IP Provisions in the Proposed EU FTA.
Priorities to Combat Counterfeiting and Piracy Koji Yonetani Director Intellectual Property Affairs Division Ministry of Foreign Affairs of Japan
Intellectual Property Rights, Services and Trade Facilitation CARSTEN FINK African/LDCs Ambassadors Seminar on Post-Hong Kong Assessment of the Doha Round,
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
WIPO’s Strategies on Intellectual Property and Economic Development WIPO’s Strategies on Intellectual Property and Economic Development United Nations.
Enforcement of Intellectual Property Rights in the Republic of Macedonia State Office of Industrial Property of the Republic of Macedonia ______________________________.
Importance of Intellectual Property Central issue in multilateral trade relations –Need for organization to see that there are intellectual property procedures.
The WIPO Development Agenda: An Overview Geneva May, 2009 Esteban Burrone World Intellectual Property Organization.
IPR enforcement in the EU Evidence of impact of on the access to generics Johanna von Braun University of Cape Town, South Africa Kiev, 21/22 nd June 2010.
Ministerstwo Gospodarki Counterfeiting and other problems in plant protection products marketing (presentation of ) Zbigniew Barszcz Department.
The emergence of an Enforcement Agenda Intellectual Property Rights and Access to Essential Medicines: Challenges and Opportunities in Free Trade Agreement.
PATENTS AND HEALTH. A CASE STUDY OF THE UGANDAN CONTEXT. (PHA3 JULY 7 TH 2012 –CAPE TOWN, SOUTH AFRICA) MS. MARIAM AKIROR LLB (HONS) / DIP. SW / CPC. PROG.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
IP LAW AND ADMINISTRATION IN TANZANIA Presented by: Leonila Kishebuka Deputy Registrar, Business Registrations and Licensing Agency [BRELA],
Overview +Recap +Legal framework - points of interest +Next steps +Questions.
How can the WTO better integrate the poorest countries into the international IP system? Arno Hold Research Fellow, NCCR Trade Regulation World Trade Institute,
NOIP: Challenges and Strategies IPRTA forum Mexico City, July 9-11, 2008 Pham Phi Anh Deputy Director General National Office of Intellectual Property.
An Introduction to IPR Enforcement Tony Bonnici UNECE Skopje, 1 April 2009.
CAPACITY BUILDING TRAINING PROGRAMME ON INTELLECTUAL PROPERTY RIGHTS AND RELATED WTO ISSUES April 28-May 2, 2008 Session 3 Enforcement under the TRIPS.
WHO Perspective on Medicine Patents and FTAs Asian Regional Workshop on FTAs August, 2005, Kuala Lumpur, Malaysia Dr Zafar Mirza Regional Adviser,
Zimbabwe CSOs TRIPS and Access to medicines Aulline Mabika-Chapisa.
1 n June 2005European Commission KTC Seminar Seoul – 2 June 2004 The fight against counterfeiting and piracy: The fight against counterfeiting and piracy:
Ideas in Development The Potential Impact of WTO Accession, FTAs and Partnership & Cooperation Agreements (PCAs) on Access to Medicines.
The Doha Declaration and the Protocol amending the TRIPS Agreement Islamabad, 28 November 2007 Octavio Espinosa WIPO.
UNCTAD/CD-TFT 1 Exclusive Rights and Public Access – Flexibilities in International Agreements and Development Objectives The Public Health Example 21.
Implementing the WIPO Development Agenda: Comparing National Approaches to Promoting Coherence Between Public Policy Objectives and IP Laws ICTSD Roundtable.
© 2008 International Intellectual Property June 24, 2009 Class 8 Patents: Multilateral Agreements (WTO TRIPS); Global Problem of Patent Protection for.
UNCTAD/CD-TFT 1 IP Provisions in Bilateral & Regional Trade Agreements and Public Health ICTSD/QUNO Dinner Discussion on IPRs in Bilateral & Regional Trade.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
Regional Dialogue on EPAs, IP and Sustainable Development for ECOWAS Countries Dialogue organised by ICTSD, ENDA Tiers Monde & QUNO Saly (Dakar), Senegal,
SNB - REACT Business Perspective IPR Protection April 1, 2009 Presentation Eli Mufisovski.
Agreement on TRIPS TRIPS Agreement  When the WTO was established, it led to 18 specific agreements to which all members need to adhere. Members necessarily.
International cooperation in combating IP crimes: Criminal IP enforcement in the international policy debate Heike Wollgast World Intellectual Property.
Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies By Yvonne Nkrumah Legal Counsel, Ghana Food and Drugs Board.
Enforcement under the TRIPS Agreement [Shortened version of presentation] Regional Conference – IP Enforcement Cairo, November 9, 2008 Ms. Louise van Greunen.
WARSAW May 2006 Seminar on Enforcement of Property Variety Rights.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA RECAP ON PROCEEDINGS OF DAY 1 George Mpundu.
Standing Committee on the Law of Patents Standing Committee on the Law of Patents Created in 1998, it ‘serves as a forum to discuss issues, facilitate.
Japan’s Perspective on Combating Counterfeiting and Piracy Third Global Congress on Combating Counterfeiting and Piracy Hisamitsu Arai January 30, 2007.
The Intellectual Property Provisions of Recent US FTAs CARSTEN FINK Video Conference for Andean Countries on Intellectual Property Rights, May 4, 2005.
Three Pillars of the Copyright System Any efficient copyright system must include: 1) appropriate legislation 2) management mechanisms 3) enforcement.
Durban, South Africa January 29 to 31, 2013 Topic 13: The Effective Administrative Process for the Grant of Compulsory Licenses Regional Seminar for Certain.
The Directive on Enforcement and The Customs Regulation Warsaw May 2006 Martin Ekvad Community Plant Variety Office Head of Legal Affairs.
TRIPS-Plus Pressures: Trade Agreements, and New Trade Policy Prof. Brook K. Baker OSI Kiev – IPRs & A2M, Sept. 16, 2009.
ABA Annual Meeting All Rights Reserved Brief Overview of the Intellectual Property System in China Elizabeth Chien-Hale
ANTI COUNTERFEIT FROM COMMUNITY PERSPECTIVE -Estimates indicates 30% of drugs in Kenyan market are fake. -40 billion lost every year due to counterfeit.
ACTA & Public Safety: Counterfeit Agreement Peter Maybarduk Public Citizen October 28, 2010.
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
ANTI-COUNTERFEITING TRADE AGREEMENT
International IP Roundtable UNLV, 8 April Seizure of Goods in Transit
IPR’s: new challenges and opportunities
IP Provisions in Bilateral & Regional Trade Agreements and Public Health ICTSD/QUNO Dinner Discussion on IPRs in Bilateral & Regional Trade Agreements.
Presentation transcript:

The Emergence of Anti-Counterfeiting Legislation in East Africa: Implications for Generic Supply and Treatment Access Mandeep Dhaliwal Tenu Avafia With assistance from Boyan Konstantinov HIV/AIDS Practice, UNDP BDP

Key Provisions on IP Enforcement in TRIPS TRIPS contains checks and balances on the application of procedures and defining remedies Infringement to be determined in each jurisdiction Procedures for border measures, criminal procedures and penalties must be provided required only for cases of willful trademark counterfeit or copyright piracy on a commercial scale “Proportionality of the measure to the seriousness of the infringement.” (Art.46 ) 2

3 The Broader Enforcement Agenda (Source: Viviana Munoz Tellez, South Centre) The TRIPS Agreement Mandatory obligations on IPR enforcement for WTO member states Room for flexibilities for implementation The World Intellectual Property Organization Advisory Committee on IP Enforcement (ACE) WTO TRIPS Council Dispute Settlement Accession Protocols Anti-Counterfeiting Trade Agreement (ACTA) OECD Studies on Economic Impact of Counterfeiting and Piracy US Special 301 Report EU strategy on IPR enforcement in third countries Bilateral/Bilateral FTAs - EPAs TRIPS-Plus enforcement obligations World Customs Organization Standards and model law to strengthen IPR enforcement via border measures Group of Eight Coordinated IP enforcement strategy World Health Organization IMPACT Working Group on Counterfeit Medicines Global Congress on Anti- Counterfeiting and Piracy WCO, Interpol, WIPO and Iidustry Technical Assistance WIPO-WTO agreement Model laws Interpol fight IPR crime, links to terrorism Universal Postal Union Increase involvement of postal administrations in IPR enforcement

Impact of IP Enforcement on Access to Medicines Problem with substandard /spurious medicines pose a real threat to patients Attempts to address problem by adopting IP enforcement measures raise serious concerns because they: –conflate intellectual property concerns with medicine quality which is different; –delegate enforcement to authorities with no adequate competency to determine IP infringement or medicines’ quality and efficacy; –divert substantial public resources to defend private rights.

Impact of IP Enforcement on Access to Medicines No evidence that IP enforcement provides sustainable protection against substandard medicines Growing evidence that enforcement of IP border measures by European Union impacting negatively on public health In , at customs in Europe: about 17 seizures of legitimate generics (including ARVs), for developing countries, as “counterfeit” This has led to a request for consultations filed before the WTO by Brazil and India

Proliferation of Anti-Counterfeiting Legislation in the EAC EAC comprises of 5 countries, 4 of which are LDCs EAC countries could and should benefit from the l TRIPS flexibilities for such countries Instead, we see developing of “anti-counterfeit” legislation, which could prevent them from utilizing TRIPS flexibilities Tanzania, Subsidiary Merchandise Marks Act, 2008; Kenya, Anti-Counterfeiting Act,2008; Uganda, discussing a Counterfeit Goods Bill since 2008 Draft EAC Anti-counterfeit and Bill are being discussed UN Special Rapporteur on the Right to Health has expressed concerns about public health impact of draft Policy and Bill in letters to the governments of all EAC countries

Kenya’s Anti-counterfeit Act of 2008 Adopted in 2008 Conflates quality and IPR issues; legitimate generics fall under definition of “counterfeits” Up to 90% of medicines in Kenya are generics (Source: HAI-Africa) Act was challenged before the High Court in July 2009 by three petitioners living with HIV. Court passed preliminary judgment in favor of petitioners on 23 April, 2010 Court suspended powers of Anti-Counterfeit Agency to interfere with importation and distribution of generics pending ruling on the substance (Source: HAI-Africa) In June 2010, unnamed Health Ministry officials conceded that Act was promoted by Kenya’s Industry Ministry without public health considerations (Source: Economic Times of India)

Uganda’s Counterfeit Goods Bill About 85-90% of medicines in Uganda are imported, up to 93% are generics (Sources: IPS, HEPS-Uganda) As a LDC, Uganda does not have to protect IPRs until July 2013 (2016 for pharmaceuticals) Counterfeit Goods Bill – discussed since Initial definition of “counterfeit” very similar to Kenya’s law, TRIPS-plus. Included patents, covered generics Civil society concerns: Bill trades away TRIPS public health flexibilities, hampers access to essential medicines, obstructs local production capacity development

Uganda’s Counterfeit Goods Bill UNDP: co-sponsored an expert discussion on the Bill (Entebbe, September 2009). International experts and domestic policy makers examined Bill from public health perspective: TRIPS-plus definition of “counterfeit”, contradiction with other laws, border measures, criminal sanctions Government decided to exclude patents from Bill Question whether it is at all needed remains. Uganda has comprehensive IP and medicine quality control legislation In March 2010, Industry Minister admitted that the EU has supported Bill’s development, as part of the Economic Partnership Agreement (Sources: IPS, PIJIP)

Draft EAC Anti-Counterfeiting Policy and Bill on Access to Essential Medicines Definition problems – what is “counterfeit”? Danger of IP enforcement abuse Efficiency concerns – does IP enforcement actually prevent spread of substandard medicines? Cost-benefit dilemma – enforcement at all cost?

Determining a Constructive Agenda Develop adequate measures to show no tolerance for substandard medicines. IPR enforcement : not an adequate approach. IPRs are private rights that regulate use of protected objects. Not suitable to ensure safety and efficacy of medicines. Likely to hamper access to generics. National drug regulatory authorities should implement safety and efficacy measures for medicines. Countries should create legal and policy environment that enables implementation of the MDGs, including Goals 4, 5, and 6. Developing and least developed WTO members should utilize TRIPS public health flexibilities and avoid TRIPS-plus measures.

Photos have been provided by HAI-Africa THANK YOU